The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic review

• Váldodahkkit: Alison Adams (Dahkki), Sarin Blawatt (Dahkki), Tianna Magel (Dahkki), Scott MacDonald (Dahkki), Julie Lajeunesse (Dahkki), Scott Harrison (Dahkki), David Byres (Dahkki), Martin T. Schechter (Dahkki), Eugenia Oviedo-Joekes (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2023-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods systematic review to explore the impact of these changes on program effectiveness and client experiences in OAT. Methods The...